Damora Therapeutics, Inc.

DMRA·NasdaqCM·Healthcare
Compare
22.94+0.86 (+3.89%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close22.08
Open23.37
Day range21.4523.40
52-week range4.9538.33
Off day high−1.97%
Off 52-week high−40.14%
Volume736.74K
Avg. volume (3M)531.19K
Market cap1.42B
EPS (TTM)-0.2500
Forward P/E-10.56
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.51
Shares outstanding61.74M
Short interest9.74% of float
Earnings dateNov 4, 2026
Analyst target46.89
Profit margin0.00%

Against its peers

Compare in full ›
DMRA SNDX COAG DMAC DNTH RCUS
Market cap 1.42B 940.80M 2.11B 580.78M 4.80B 2.43B
P/E (TTM) — — — — — —
Forward P/E -10.6 -14.4 -17.7 -14.4 -18.6 -6.2
Price/book -0.2 -54.7 4.6 15.1 7.5 3.8
Dividend yield — — — — — —
1-year change +294.16% −28.86% +26.76% +50.38% +135.55% −1.28%
Today +3.89% −26.87% +4.62% +7.70% +3.76% +2.12%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All DMRA news ›

From the 4Search news index, newest first.

In the news

1mentions in 30 days
1with it in the headline
Negativesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance